About Nanolattix

Nanolattix Group is an overseas core technical team led by Dr. Zhican Qu, a high-level overseas life science talent introduced by the state, responding to the call of Shanxi Province's economic transformation, carrying independent intellectual property biotechnology and start-up capital, and setting up a national high-tech enterprise integrating product research and development, technology output, production and sales. Nanolattix takes life and health as its core, focusing on innovation and technological transformation in the fields of medical medicine and general health. Its business covers biomedicine, medical devices, plant extraction, precision health and other industries. So far, the entrepreneurial team led by Dr. Zhican Qu has declared more than 50 invention patents in the field of biomedicine, insisting on multi-level innovation, rapidly transforming scientific research results, self-making and rolling forward.

2016 Year

Date of Establishment

50 Remainder

Authorized patent

Learn more +

Nanolattix Biology

Nanolattix Biology has set up a Bio-Lattix core biotechnology platform, covering three modules: drug target screening, antibody engineering and ADC patent drug research. It has established more than 10 new drug development pipelines such as monoclonal antibody ADC, double antibody ADC and nano antibody ADC, and deployed 7 development pipelines of RDC innovative drugs for precision internal radiotherapy coupled with antibody and radioisotope. The core product T320 anticancer drug targets a variety of solid tumors such as cervical cancer, pancreatic cancer, and non-small cell lung cancer. The drug has been recognized by the US FDA for pancreatic cancer ODD (orphan drug) and will fill the gap in the new target of national biomedicine., Strive to be listed in two to three years, and is expected to have a market potential of over 10 billion yuan.

Nanolattix Health

In the future, Nanolattix takes biotechnology as its mission to empower human health and strives to become an internationally renowned pharmaceutical and health industry group.

Learn more +